Dec 24, 2025
De Facto Combinations: Why Some Patients Take Separate Generics Instead of Fixed-Dose Combinations
Tag: pharmacovigilance
How the FDA Monitors Generic Drug Safety After Approval
Read More
Learn how the FDA uses FAERS, the Sentinel Initiative, and factory inspections to ensure generic drugs remain safe and effective after they hit the market.
How to Report Serious Adverse Events for Generic Drugs: A Guide for Providers
Read More
Learn the exact procedures for reporting serious adverse events for generic drugs, including how to use MedWatch and identify manufacturers using NDC codes.
Dechallenge and Rechallenge in Drug Side Effects: What These Tests Mean
Read More
Dechallenge and rechallenge are key clinical tools used to determine if a drug is causing side effects. Stopping the drug (dechallenge) and safely restarting it (rechallenge) can confirm causality-helping doctors make safer treatment decisions.
